ARTA
SIOX

A.R.T. Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

A.R.T. Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,271
Closed -$131K – 1835
2019
Q3 		$131K Buy
+20,271
New +$140K 0.01% 1242
2018
Q2 		– Sell
-52,038
Closed -$553K – 1857
2018
Q1 		$553K Buy
52,038
+31,134
+149% +$500K 0.02% 914
2017
Q4 		$881K Buy
20,904
+11,643
+126% +$522K 0.04% 673
2017
Q3 		$509K Buy
9,261
+3,225
+53% +$544K 0.03% 821
2017
Q2 		$1.12M Buy
+6,036
New +$1.06M 0.06% 471
2016
Q3 		– Sell
-5,763
Closed -$591K – 1272
2016
Q2 		$591K Buy
+5,763
New +$576K 0.03% 747

Other funds holding SIOX

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $2.1B AUM 70.99% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.3B AUM 46.46% 1-Year Est. Return